Mechanism and role of growth arrest in programmed (apoptotic) death of prostatic cancer cells induced by thapsigargin

Prostate

Volumn 33, Issue 3, 1997, Pages 201-207

  Lin, Xiaohui S ^a   Denmeade, Samuel R ^a   Cisek, Lars ^b   Isaacs, John T ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Calcium; Gadd153; Growth arrest; Programmed cell death; Thapsigargin

Indexed keywords

CALCIUM; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; THAPSIGARGIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CANCER INHIBITION; DOSE TIME EFFECT RELATION; DRUG MECHANISM; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; RAT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CALCIUM; CELL DIVISION; CHELATING AGENTS; DNA DAMAGE; DNA, NEOPLASM; EGTAZIC ACID; FLOW CYTOMETRY; FLOXURIDINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS; RATS; RNA, MESSENGER; RNA, NEOPLASM; THAPSIGARGIN; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0030690164     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19971101)33:3<201::AID-PROS9>3.0.CO;2-L     Document Type: Article

References (20)

1. Crawford ED, Eisenberger MA, McLeod DC, Spaulding J, Benson R, Dorr FA, Blumenstein BA, Davis MA, Goodman PJ: A control randomized trial of Leuprolide with and without flutamide in prostatic cancer. N Eng J Med 1989;321:419-424.
2. Kyprianou N, England HF, Isaacs JT: Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 1990;50:3748-3753.
3. Denmeade SR, Lin XS, Isaacs JT: Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate 1996;28:251-265.
4. Kyprianou N, Isaacs JT: "Thymineless" death in androgen-independent prostatic cancer cells. Biochem Biophys Res Commun 1989;165:73-81.
5. Kyprianou N, Bains AK, Jacobs SC: Induction of apoptosis in androgen-independent human prostate cancer cells undergoing thymineless death. Prostate 1994;25:66-75.
6. Furuya Y, Isaacs JT: Proliferation-dependent vs. independent programmed cell death of prostatic cancer cells involves distinct gene regulation. Prostate 1994;25:301-309.
7. Furuya Y, Krajewski S, Epstein JI, Reed JC, Isaacs JT: Expression of bcl-2 and the progression of human and rodent prostate cancers. Clin Cancer Res 1996;2:389-398.
8. Berges RR, Vukanovic J, Epstein JI, CarMichael M, Cisek L, Johnson DE, Veltri RW, Walsh PC, Isaacs JT: Implication of the cell kinetic changes during the progression of human prostatic cancer. Clin Cancer Res 1995;1:473-480.
9. Yagoda A, Petrylak D: Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. Cancer 1993;71:1098-1109.
10. Furuya Y, Lundmo P, Short AD, Gill DL, Isaacs JT: The role of calcium pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res 1994;54:6167-6175.
11. Kung AL, Zetterberg A, Sherwood SW, Schimke RT: Cytotoxic effects of cell cycle phase specific agents: results of cell cycle perturbation. Cancer Res 1990;50:7307-7317.
12. Bartlett JD, Luethy JD, Carlson SG, Sollott SJ, Holbrook NJ: Calcium ionophore A23187 induces expression of the growth arrest and DNA damage inducible CCAAT/enhancer-binding protein (C/EBP)-related gene, gadd153. J Biol Chem 1992;267:20465-20470.
13. 1/S arrest. Genes Dev 1994;8:453-464.
14. Ron D, Habener JF: CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 1992;6:439-453.
15. Fornace AJ Jr, Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Forgnoli J, Holbrook NJ: Mammalian genes coordinately regulated by growth arrest and DNA-damaging agents. Mol Cell Biol 1989;9:4196-4203.
16. Vindeløv LL, Christensen IJ, Nissen NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1993;3:323-327.
17. Ghosh TK, Bian J, Short AD, Rybak SL, Gill DL: Persistent intracellular calcium pool depletion by thapsigargin and its influence on cell growth. J Biol Chem 1991;266:24690-24697.
18. 2+ indicators with greatly improved fluorescent properties. J Biol Chem 1985;260:3340-3350.
19. Schwating R, Gerdes J, Jaeschke L, Stein H: Determination of the growth fraction in cells suspensions by flow cytometry using the monoclonal antibody Ki-67. J Immunol Methods 1986;90:65-70.
20. Denmeade SR, Isaacs JT: Activation of programmed (apoptotic) cell death for the treatment of prostate cancer. In August J, Anders M, Murad F, Coyle J (eds): "Advances in Pharmacology." San Diego: Academic Press, 1996:281-306.